Satin Creditcare Q1 Results: Consolidated Net Profit Surges 172% YoY to ₹1,226 Lakh
Satin Creditcare reported a strong Q1 performance with consolidated net profit rising 172% YoY to ₹1,226.46 lakh and standalone profit up 182% to ₹1,202.87 lakh, supported by an 8.4% increase in consolidated revenue to ₹7,621.36 lakh and a significant decline in impairment charges. The company also raised substantial capital through NCDs and USD-denominated bonds, while making strategic investments in its subsidiaries.

*this image is generated using AI for illustrative purposes only.
Satin Creditcare reported a significant surge in profitability for the quarter ended June 30, 2026, with standalone net profit after tax reaching ₹1,202.87 lakh, compared to ₹426.01 lakh in Q1FY25. The consolidated net profit rose 172% year-on-year to ₹1,226.46 lakh from ₹450.99 lakh, driven by strong interest income growth and effective cost management. This performance underscores the company's ability to generate value despite broader economic headwinds.
The Board of Directors approved the unaudited financial results on July 30, 2026, following a review by the Audit Committee. The results were limited reviewed by J C Bhalla & Co., the statutory auditors, who issued an unmodified opinion pursuant to Regulations 30, 33, 52, and 63 of the SEBI Listing Regulations. Trading in the company's securities remained closed until 48 hours after the announcement.
Financial Performance Highlights
Interest income emerged as the primary growth driver, rising to ₹6,320.30 lakh (standalone) and ₹7,139.62 lakh (consolidated) from ₹5,557.89 lakh and ₹6,152.57 lakh respectively in the corresponding quarter of the previous year. Total revenue from operations increased to ₹6,709.08 lakh (standalone) and ₹7,621.36 lakh (consolidated), reflecting a 5.4% and 8.4% year-on-year growth respectively.
| Metric: | Standalone (₹ in Lakhs) | Consolidated (₹ in Lakhs) | Q1FY25 Standalone (₹ in Lakhs) | Q1FY25 Consolidated (₹ in Lakhs) |
|---|---|---|---|---|
| Interest Income: | 6,320.30 | 7,139.62 | 5,557.89 | 6,152.57 |
| Total Revenue: | 6,709.08 | 7,621.36 | 6,365.99 | 7,031.51 |
| Impairment Charges: | 1,001.49 | 1,061.21 | 1,346.36 | 1,428.80 |
| Net Profit After Tax: | 1,202.87 | 1,226.46 | 426.01 | 451.00 |
Impairment of financial instruments declined to ₹1,001.49 lakh (standalone) from ₹1,346.36 lakh in Q1FY25, indicating improved asset quality or better provisioning efficiency. Employee benefit expenses remained stable at ₹1,571.64 lakh (standalone), while finance costs increased moderately to ₹2,688.88 lakh due to higher interest costs offset by foreign exchange gains.
Capital Raises and Strategic Investments
During the quarter, the company raised capital through private placements. It allotted non-convertible debentures aggregating ₹8,446.00 lakh to two investors on May 26, 2026, and secured United States Dollars denominated bonds worth ₹19,046.00 lakh to one investor on May 27, 2026. Additionally, the group issued senior secured NCDs totaling ₹17,000.00 lakh across multiple tranches between April and June 2026.
Strategically, Satin Creditcare invested ₹1,000.00 lakh in its wholly-owned subsidiary Satin Technologies Limited and ₹5,000.00 lakh in Satin Finserv Limited via rights issues. Subsequent to the quarter-end, it further invested ₹1,200.00 lakh in Satin Growth Alternatives Limited. These moves signal continued expansion within its fintech ecosystem.
What the Numbers Show
The divergence between revenue growth and profit expansion highlights operational leverage. While revenue grew modestly by 5-8%, net profit more than tripled, largely due to a 25% reduction in impairment charges and stable operating expenses. This suggests that core lending operations are becoming more efficient, with credit costs easing significantly compared to the prior year period.
Historical Stock Returns for Satin Creditcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.40% | +2.21% | +9.13% | +66.86% | +76.13% | +199.67% |
How sustainable is the current reduction in impairment charges, and does it signal a permanent improvement in asset quality or a temporary cyclical dip in credit costs?
What is the impact of the recent USD-denominated bond issuance on the company's foreign exchange exposure and future interest cost volatility?
Will the capital raised through NCDs and private placements be primarily allocated to expanding the loan book or strengthening the balance sheet to meet regulatory requirements?


































